{
  "abstract": "Objective: Identifying individuals at higher pain medication-related risk may help promote safer, more personalized pain management. This study aimed to identify factors associated with trajectories of pain medication-related risk.\n\nDesign: Retrospective cohort study.\n\nParticipants: Data from the TorSaDE Cohort, which links survey and health administrative data in Quebec, Canada, were used to identify 8760 adults with chronic pain covered by the public drug insurance plan.\n\nOutcome: Pain medication-related risk was measured using the Medication Quantification Scale 4.0 (MQS-4.0). Monthly risk scores were calculated over the 2-year period following survey completion. Growth mixture modelling identified groups of individuals with similar patterns of risk over time (trajectories), and multivariable multinomial regression identified factors associated with trajectory membership.\n\nResults: Four distinct trajectory groups were identified in our sample: “Low stable risk” (34.1%), “Moderate stable risk” (51.0%), “Increasing to high risk” (7.5%), and “High risk decreasing” (7.4%). Membership in higher-risk trajectories was independently associated with sociodemographic factors (older age, Indigenous identity, lower educational attainment, remote residence), clinical factors (smoking, greater stress, migraine, mood and anxiety disorders, poorer self-perceived general health), and healthcare and medication-related factors (greater healthcare utilization, higher number of prescribed medications). Similar trajectory patterns were observed in females and males, whereas greater heterogeneity was observed among older adults.\n\nConclusion: Pain medication-related risk follows distinct longitudinal trajectories among adults reporting chronic pain who were covered by Quebec’s public prescription drug insurance plan. Identifying individuals at increased risk may help prioritize those with greater clinical complexity (eg, mood or anxiety disorders, migraine, high healthcare utilization, or multiple prescribed medications) for medication reviews, closer monitoring, and individualized pain management.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue (UQAT), Rouyn-Noranda, QC, Canada",
    "Patient Partner, Rouyn-Noranda, QC, Canada",
    "Research Center, Centre hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada",
    "Department of Anesthesiology and Pain Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada",
    "Population Health and Optimal Health Practices Research Unit, CHU de Québec Research Center, Université Laval, Quebec City, QC, Canada",
    "Faculté de Pharmacie, Université Laval, Québec, QC, Canada",
    "Family Medicine and Emergency Medicine Departement, Université de Sherbrooke, Sherbrooke, QC, Canada"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 7,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Hermine Lore Nguena Nguefack"
    },
    {
      "affs": [
        1
      ],
      "name": "Nancy Ménard"
    },
    {
      "affs": [
        1
      ],
      "name": "Sylvie Beaudoin"
    },
    {
      "affs": [
        2,
        3
      ],
      "name": "M Gabrielle Pagé",
      "orcid": "0000-0002-7742-2717"
    },
    {
      "affs": [
        4,
        5
      ],
      "name": "Line Guénette",
      "orcid": "0000-0001-9769-7550"
    },
    {
      "affs": [
        6
      ],
      "name": "Catherine Hudon"
    },
    {
      "affs": [
        0
      ],
      "name": "Anaïs Lacasse",
      "orcid": "0000-0002-3992-5145"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/1gwq3eab6v068.bib",
  "cited_by": 0,
  "doi": "10.2147/clep.s655117",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13759338/",
  "id": "1gwq3eab6v068",
  "issns": [
    "1179-1349"
  ],
  "landing_url": "https://doi.org/10.2147/clep.s655117",
  "language": "en",
  "licence": "CC-BY-NC-4.0",
  "licence_label": "CC BY-NC 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Original Research"
    ],
    [
      "openalex",
      "2739|Opioid Use Disorder Treatment"
    ]
  ],
  "openalex": "W7225463422",
  "pdf_url": "https://www.dovepress.com/article/download/122026",
  "pmcid": "PMC13759338",
  "pmid": "43031653",
  "published": "2026-11-08",
  "publisher": "Dove Press",
  "ris": "https://research.draconitic.com/paper/1gwq3eab6v068.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:59Z",
      "native_id": "PMC13759338",
      "source": "pmc",
      "url": "https://doi.org/10.2147/clep.s655117"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2739|Opioid Use Disorder Treatment",
      "subfield": "epidemiology-public-health"
    }
  ],
  "title": "Factors Associated with Higher Pain Medication-Related Risk Trajectories in Quebec, Canada: A Cohort Study Using Health Administrative Data",
  "title_text": "Factors Associated with Higher Pain Medication-Related Risk Trajectories in Quebec, Canada: A Cohort Study Using Health Administrative Data",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:59Z",
  "url": "https://research.draconitic.com/paper/1gwq3eab6v068",
  "venue": "Clinical Epidemiology",
  "versions": []
}